Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Medtronic
US Department of Justice
Boehringer Ingelheim
Baxter
US Army
Accenture
QuintilesIMS
Chinese Patent Office

Generated: November 14, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021365

« Back to Dashboard

NDA 021365 describes LEXAPRO, which is a drug marketed by Allergan Sales Llc and is included in two NDAs. It is available from twelve suppliers. There are two patents protecting this drug and two Paragraph IV challenges. Additional details are available on the LEXAPRO profile page.

The generic ingredient in LEXAPRO is escitalopram oxalate. There are twenty-six drug master file entries for this compound. Sixty-one suppliers are listed for this compound. Additional details are available on the escitalopram oxalate profile page.
Summary for 021365
Tradename:LEXAPRO
Applicant:Allergan Sales Llc
Ingredient:escitalopram oxalate
Patents:0

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrengthEQ 5MG BASE/5ML
Approval Date:Nov 27, 2002TE:AARLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Daiichi Sankyo
McKinsey
Federal Trade Commission
Cerilliant
Colorcon
Merck
Fuji
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.